Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Body temperature is elevated and linked to fatigue in relapsing-remitting multiple sclerosis, even without heat exposure.
Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis.
Few MS Patients Fail to Receive Disease-Modifying Therapy
Episode 81 with Dr. Kaarina Kowalec
MS May Impair Cerebellar Regional Functional Connectivity
MS Research Roundup: April 18, 2014
Phase II Study Showed Ocrelizumab Maintained Significant Reduction in Disease Activity for Multiple Sclerosis Patients for Almost Two Years
Enzyme, Exposed
Dietary patterns not associated with the risk of multiple sclerosis
A Study of Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis
CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma.
A Study of Ocrelizumab in Comparison with Interferon Beta 1a (Rebif) in Patients with Relapsing Multiple Sclerosis
Depletion of B cells by a humanized anti-CD20 antibody PRO70769 in Macaca fascicularis.
Channeling MS
Neuromyelitis optica: not a multiple sclerosis variant.
Andiamo! Moving forward with autologous hematopoietic transplantation for highly active MS
MS Research Roundup: December 2, 2014
MS Patient, Ph.D.: Patience, the Rusty Adjective
Experimental models of multiple sclerosis.
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Core Value of Amyloids
A Study of Ocrelizumab in Comparison with Interferon Beta 1a (Rebif) in Patients with Relapsing Multiple Sclerosis
Preferred sources of health information in persons with multiple sclerosis: degree of trust and information sought.
Autologous hematopoietic stem cell transplantation in multiple sclerosis A phase II trial
Pages
« first
‹ previous
…
37
38
39
40
41
42
43
44
45
…
next ›
last »
